Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City

Launched by NATIONAL INSTITUTE OF RESPIRATORY DISEASES, MEXICO · Jan 12, 2023

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Positive ELISA test or positive viral load for HIV.
• * Patients with suspected or confirmed advanced HIV disease defined as follows:
• • Confirmed: asymptomatic patients with CD4 count less than 200 cells/ml within 3 months of study inclusion or confirmed diagnosis of an AIDS-defining opportunistic illness within the last 3 months.
• • Suspected: patients who, irrespective of CD4 count, present any symptoms suggestive of systemic infection that, at the discretion of the treating physicians, produce suspicion of an AIDS-defining opportunistic disease (e.g., fever, productive cough, diaphragmatic diapers, etc.). Fever, productive cough, nocturnal diaphoresis, altered mental status, headache, lymphadenopathy, dermatological lesions) or that meet criteria for HIV wasting syndrome (loss of 10% of baseline weight plus the presence of chronic diarrhea or chronic weakness and an episode of fever in the last 30 days).
• • Patients without effective antiretroviral therapy defined as not having received antiretroviral treatment in the last 3 months or in virologic failure (2 consecutive viral loads with more than 1000 copies/ml).
• Exclusion Criteria:
• • Patients with a viral load of less than 1000 copies/ml.
• • Patients presenting for care having started treatment for systemic mycoses (amphotericin B or azoles) and tuberculosis.